Objective: To assess the epidemiology of methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) infections in a neonatal intensive care unit (NICU).
Introduction
Staphylococcus aureus is a well known pathogen among infants hospitalized in the neonatal intensive care unit (NICU). 1 However, there are few recent data estimating the rate of infections caused by S. aureus or describing clinical presentations, including potential differences in the clinical presentations of methicillin-susceptible S. aureus (MSSA) versus methicillin-resistant S. aureus (MRSA), particularly in the era of community-acquired MRSA strains. 2, 3 Thus, we sought to determine potential changes in the epidemiology of infections caused by MSSA and MRSA in our NICU from 2000-2007.
Methods

Study design and study site
This retrospective study was carried out in the level III NICU of a university-affiliated children's hospital in New York City, NY, USA. In November 2003, the NICU was relocated to a new building, with more space allocated to each infant and the number of beds increased from 45 to 62. By 2007, the NICU had approximately 1100 annual admissions and 25% of infants were transferred from other institutions. Approximately 40% of infants were full-term neonates, many of whom underwent surgery for congenital anomalies. The complexity of the patients also increased during the study period as documented by the increase in Case Mix Index. Targeted surveillance for antibiotic resistant bacteria was carried out as previously described. 4, 5 The study was approved by the Institutional Review Board of Columbia University Medical Center, which granted a waiver of documentation of informed consent.
Case definitions for infections
The hospital's computerized information system was used to create a list of infants hospitalized in the NICU with positive cultures for either MSSA or MRSA from 1 January 2000 to 31 December 2007. Individual records were examined to confirm infections defined as positive cultures of sterile body sites (for example, the bloodstream) or invasive skin and soft tissue infections (SSTIs). Patients were considered to have invasive SSTIs if there was documentation of treatment with parenteral antibiotics, and they fulfilled the following criteria: (1) purulent drainage from central line insertion site; (2) drainage or dehiscence from a surgical wound; (3) cellulitis; or (4) abscess. If a patient had a positive culture from more than one body site (for example, the bloodstream and SSTI), all infected sites were included in the descriptive analysis. If a patient had more than one episode of infection with S. aureus (n ¼ 3), only the first infection was included in the analysis. Positive cultures from skin lesions or the conjunctiva treated with topical antibiotics, or surveillance cultures of the anterior nares were not included in the analysis.
Microbiological processing
Cultures obtained for clinical purposes were processed according to published guidelines. 6 Species identification and antimicrobial susceptibility testing were carried out using the MicroScan WalkAway instrument (Positive Breakpoint Combo panel Type 65; Dade Microscan, West Sacramento, CA, USA). Isolates were characterized as susceptible, intermediate or resistant as defined by published criteria. 7 The first isolate for each infection was used in the analysis of antimicrobial susceptibility.
Statistical analysis
The w 2 -test was used to compare proportions between groups, unless noted that Fisher's exact test was applied. The permutation test was used to compare the distributions of continuous variables between groups. R, a language and environment for statistical computing and graphics, was used for additional data analysis. 8 
Results
Characteristics of infected infants
The characteristics of infants infected with MRSA versus MSSA are shown in Table 1 . The infants were similar in terms of sex, gestational age and birth weight. During the study period, there were 123 infections caused by MSSA and 49 infections caused by MRSA. Overall, the clinical presentations and the crude mortality rates were similar in both groups. However, infants with MRSA infections were significantly younger at clinical presentation than infants with MSSA infections. Of the 22 infants with post-operative wound infections, 19 were full-term infants of whom 12 had MSSA and 7 had MRSA infections. Of the 8 infants with osteomyelitis, all had coincident SSTI or bacteremia.
Rates of MSSA and MRSA infections During the study period, the rate of MSSA and MRSA infections ranged from 15 to 30 infections per 1000 patient-admissions ( Figure 1 ). The rate of primary bacteremia and SSTIs remained stable and was unaffected by the relocation of the NICU to a new, more spacious facility in late 2003. However, it was difficult to assess the changing rates of infections due to outbreaks, defined as three or more cases of temporally related infection/colonization The risk of developing an infection with MSSA or MRSA was inversely proportional to birth weight (Table 2 ). Among extremely low birth weight infants (birth weight <1000 g), 4.8% and 1.8% developed an infection caused by MSSA or MRSA, respectively. In our study population, infections occurred in a bimodal distribution of birth weight ( Figure 2) ; 53% of infections occurred in extremely low birth weight infants and 27% occurred among term infants X2500 g. The majority of infected infants X2500 g had undergone surgical procedures.
Antimicrobial susceptibility
The proportion of strains resistant to various antimicrobial agents is shown in Table 3 . The majority of MRSA strains were resistant to erythromycin and levofloxacin, and many were resistant to clindamycin and gentamicin. The D-test to detect clindamycin resistance was introduced by our laboratory in April 2004. In contrast, both MSSA and MRSA were generally susceptible to rifampin, tetracycline and trimethoprim/sulfamethoxazole. During the study period, the patterns of antimicrobial susceptibility did not appear to change. Discussion This is one of the few recent studies describing the epidemiology of S. aureus in the NICU population. During the study period, we did The D-test to detect clindamycin resistance was introduced in April 2004.
Epidemiology of S. aureus in a NICU AJ Carey et al not detect differences in the types of infections or the clinical presentations caused by MRSA and MSSA infections. We were unable to determine a change in the rate of S. aureus infections, as several outbreaks occurred during the study period. However, infants with MRSA infections were younger at presentation than infants with MSSA infections. We speculate that the earlier onset of MRSA infections when compared with MSSA infections may be because of vertical transmission 9,10 amplified by patient-to-patient transmission. 11 Chen et al. 9 found that 0.4% of pregnant women had vaginal colonization with community-associated (CA) MRSA. Also, we previously reported an outbreak of the USA 300 clone on our post-partum unit, leading to several cases of mastitis and wound infection.
11 Therefore, both maternal colonization and infection with CA-MRSA do occur, although we did not assess maternal rates of MRSA colonization or infection in relationship to this study cohort.
The effect of S. aureus in the NICU has been recently investigated by others. The National Institute of Child Health and Human Development Neonatal Research Network reported that from 1998 to 2000, 7.8% of first episodes of late-onset sepsis among very low birth weight infants (birth weight <1500 g) were caused by S. aureus, but this report did not distinguish between MSSA and MRSA. 1 The excess cost associated with an infection with MRSA versus no infection or infection with MSSA has been estimated to be $9275 to $27 000. 12, 13 The difference in cost between MSSA and MRSA infections could be because of delayed initiation of appropriate treatment versus a true difference in virulence. However, Kuint et al.
2 did not demonstrate a difference in risk factors or outcomes among NICU patients with bacteremia caused by CA-MRSA, multidrug-resistant MRSA or MSSA.
Skin and soft tissue infections are common manifestations of S. aureus infections. [14] [15] [16] Recently, we and others have noted a change in the strains causing MRSA infections in the NICU; hospital-acquired strains have been replaced by (CA) strains, including USA 300. 17, 18 Jahamy et al. 19 recently reported that compared with MSSA and hospital-acquired MRSA, CA-MRSA caused more abscesses in an adult population. Thus, we had speculated that MRSA would be more likely to cause invasive SSTIs than MSSA, and that the rate of SSTIs would increase during the study period as CA-MRSA became more prevalent in the NICU. However, although nearly half (45%) of the infections in this study were SSTIs, the rate of such infections did not increase nor was MRSA more likely to cause SSTIs than MSSA.
Our analysis revealed a bimodal distribution of S. aureus infections in extremely low birth weight infants and term infants. Intrinsic and extrinsic risk factors for infections in pre-term infants are well described, 20 but it is likely that additional risk factors occurred in term infants and included surgical procedures and instrumentation. Although preventive strategies for post-operative wound infections have been developed for adult populations, 21 guidelines for neonates are not yet developed.
This study had some limitations. We studied a relatively small number of patients from a single NICU. Many of the infants in our NICU are term infants requiring surgery. Thus, our findings may not be generalizable. We may have underestimated the rate of infections, as we did not include pustules or conjunctivitis treated with topical antibiotics. We could not determine changes in the rate of infections due to the impact of outbreaks during the study period. Finally, we did not assess the costs associated with isolation.
In conclusion, S. aureus remains a significant pathogen in the NICU, infecting the most vulnerable patients, the extremely premature and term infants undergoing surgery. When compared with infections caused by MSSA, MRSA infections occurred in younger infants. Further work should investigate infection control strategies that effectively target the highest risk groups and determine if vertical transmission of CA-MRSA is responsible for the younger age of MRSA infected infants.
